Literature DB >> 1102589

Experimental production of granulomatous pneumonitis. Comparison of immunological and morphological sequelae with particulate and soluble antigens administered via the respiratory route.

J Salvaggio, P Phanuphak, R Stanford, D Bice, H Claman.   

Abstract

Rabbits were sensitized with either a soluble protein antigen (BSA) or a particulate thermophilic actinomycete antigen (Micropolyspora faeni) via the respiratory route, followed by monitoring of sequential morphologic changes and the humoral plus cellular immunologic response. Primary respiratory tract sensitization with BSA resulted in a humoral anti-BSA response, Arthus and delayed skin reactivity, and in some cases specific antigen-induced alveolar macrophage migration inhibition, all in the absence of pulmonary lesions. Lesions characterized by mild multifocal perivascular mononuclear cell infiltrates in the lungs developed only after secondary BSA aerosol challenge. In contrast to these findings, "primary" respiratory tract sensitization with M. faeni particulate antigen in saline solution resulted in the gradual development of extensive and progressive pulmonary interstitial and alveolar mononuclear cell infiltrates. These lesions were uniformly associated with specific serum precipitating antibody and delayed skin reactivity. Alveolar macrophage migration was significantly inhibited by Micropolyspora faeni in virtually of these animals. These results, while not excluding a primary irritant effect or Type II or III alergic tissue injury, suggest a role for delayed (cell-mediated) hypersensitivity in the pathogenesis of particulate actinomycete-induced pulmonary lesions. They also indicate that primary immunization with soluble purified protein antigens via the respiratory route can lead to systemic humoral and cell-mediated immunity without production of pulmonary lesions.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1102589     DOI: 10.1016/0091-6749(75)90130-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  11 in total

Review 1.  Polyclonal activators in pulmonary immune disease.

Authors:  W F Willoughby; J B Willoughby; G F Gerberick
Journal:  Clin Rev Allergy       Date:  1985-05

2.  Extrinsic allergic alveolitis caused by a cold water humidifier.

Authors:  A S Robertson; P S Burge; G A Wieland; M H Carmalt
Journal:  Thorax       Date:  1987-01       Impact factor: 9.139

3.  Complement in respiratory immunopathology.

Authors:  C Molina; J Brun; D Wahl
Journal:  Lung       Date:  1979       Impact factor: 2.584

4.  Experimental granulomatous lung disease in guinea pigs. Morphology and collagen analysis.

Authors:  J D Fulmer; A Flint; D E Law
Journal:  Lung       Date:  1983       Impact factor: 2.584

5.  Hypersensitivity pneumonitis in man. Light- and electron-microscopic studies of 18 lung biopsies.

Authors:  O Kawanami; F Basset; R Barrios; J G Lacronique; V J Ferrans; R G Crystal
Journal:  Am J Pathol       Date:  1983-03       Impact factor: 4.307

6.  Histopathological and immunohistological changes in the rabbit lung after experimental exposure to a purified enzyme of Micropolyspora faeni.

Authors:  M Schällibaum; M W Hess; J Nicolet; H König
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

7.  The effect of cortisone acetate on pulmonary lesions in a rabbit model of hypersensitivity pneumonitis (cortisone and hypersensitivity pneumonitis).

Authors:  F M Cashner; M R Schuyler; J E Salvaggio
Journal:  Clin Exp Immunol       Date:  1979-05       Impact factor: 4.330

8.  Chronic hypersensitivity pneumonitis produced in the rabbit by the adjuvant effect of inhaled muramyl dipeptide (MDP).

Authors:  H B Richerson; M T Suelzer; P A Swanson; J E Butler; W C Kopp; E F Rose
Journal:  Am J Pathol       Date:  1982-03       Impact factor: 4.307

Review 9.  Immunologic mechanisms of parenchymal lung injury.

Authors:  W F Willoughby; J B Willoughby
Journal:  Environ Health Perspect       Date:  1984-04       Impact factor: 9.031

10.  BN 52021 (a platelet activating factor-receptor antagonist) decreases alveolar macrophage-mediated lung injury in experimental extrinsic allergic alveolitis.

Authors:  J L Pérez-Arellano; T Martín; J M López-Novoa; M L Sánchez; A Montero; A Jiménez
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.